Oral Nitrite in Patients With Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction
Status:
Recruiting
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
The main objective of this study is to determine the clinical efficacy of oral inorganic
nitrite verses placebo and the therapeutic response with regards to exercise tolerance in
patients with pulmonary hypertension and heart failure with preserved ejection fraction
(PH-HFpEF).